全文获取类型
收费全文 | 5630篇 |
免费 | 341篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 165篇 |
儿科学 | 316篇 |
妇产科学 | 87篇 |
基础医学 | 685篇 |
口腔科学 | 197篇 |
临床医学 | 540篇 |
内科学 | 978篇 |
皮肤病学 | 53篇 |
神经病学 | 780篇 |
特种医学 | 155篇 |
外科学 | 731篇 |
综合类 | 19篇 |
一般理论 | 5篇 |
预防医学 | 424篇 |
眼科学 | 104篇 |
药学 | 279篇 |
中国医学 | 1篇 |
肿瘤学 | 454篇 |
出版年
2023年 | 20篇 |
2022年 | 36篇 |
2021年 | 64篇 |
2020年 | 61篇 |
2019年 | 61篇 |
2018年 | 106篇 |
2017年 | 81篇 |
2016年 | 141篇 |
2015年 | 104篇 |
2014年 | 131篇 |
2013年 | 275篇 |
2012年 | 311篇 |
2011年 | 338篇 |
2010年 | 178篇 |
2009年 | 184篇 |
2008年 | 372篇 |
2007年 | 369篇 |
2006年 | 349篇 |
2005年 | 406篇 |
2004年 | 383篇 |
2003年 | 356篇 |
2002年 | 345篇 |
2001年 | 143篇 |
2000年 | 166篇 |
1999年 | 98篇 |
1998年 | 66篇 |
1997年 | 60篇 |
1996年 | 48篇 |
1995年 | 56篇 |
1994年 | 49篇 |
1993年 | 51篇 |
1992年 | 42篇 |
1991年 | 31篇 |
1990年 | 32篇 |
1989年 | 22篇 |
1988年 | 21篇 |
1987年 | 11篇 |
1986年 | 30篇 |
1985年 | 28篇 |
1984年 | 27篇 |
1983年 | 36篇 |
1982年 | 46篇 |
1981年 | 21篇 |
1980年 | 36篇 |
1979年 | 23篇 |
1978年 | 21篇 |
1977年 | 18篇 |
1976年 | 20篇 |
1975年 | 13篇 |
1974年 | 16篇 |
排序方式: 共有5973条查询结果,搜索用时 15 毫秒
91.
Death following ingestion of MDMA (ecstasy) and moclobemide 总被引:3,自引:0,他引:3
Vuori E Henry JA Ojanperä I Nieminen R Savolainen T Wahlsten P Jäntti M 《Addiction (Abingdon, England)》2003,98(3):365-368
Four deaths following the ingestion of moclobemide and MDMA ('ecstasy') are described. The probable cause of death in each case was serotonin syndrome as a result of an interaction between the two drugs. As none of the victims had been prescribed moclobemide it seems that each had taken the drug to enhance the effects of MDMA, with fatal consequences. Warnings are needed against misinformed attempts to potentiate the pharmacological effects of illicit drugs. 相似文献
92.
Salomaa V Rasi V Kulathinal S Vahtera E Jauhiainen M Ehnholm C Pekkanen J 《Arteriosclerosis, thrombosis, and vascular biology》2002,22(2):353-358
The role of hemostatic factors as predictors of coronary heart disease (CHD) and total mortality is poorly understood. Therefore, we carried out a prospective cohort study in Finland. In 1992, a random population sample of 2378 men and women aged 45 to 64 years was investigated and then followed up until December 31, 1998. During the follow-up, 133 CHD events were observed; 73 were among participants free of CHD at baseline. The total number of deaths was 124. After adjustment for traditional risk factors and prevalent CHD at baseline and correction for regression dilution bias, a 1-SD increase in plasminogen was associated with a 1.41-fold (95% CI 1.09 to 1.81) increase in CHD risk. The predictive power of plasminogen depended significantly on the level of total cholesterol being stronger for persons with high cholesterol. A 1-SD increase in fibrinogen was associated with a 1.23-fold (95% CI 1.05 to 1.44) increase in all-cause mortality, but its association with CHD events did not reach statistical significance. Factor VII antigen or coagulant activity or lipoprotein(a) were not independent predictors of CHD risk. These findings support the role of plasminogen as a risk factor for CHD events. 相似文献
93.
D. Nordström Y. Lindroth L. Marsal I. Hafström C. Henrich S. Rantapää-Dahlqvist F. Fyhrquist C. Friman E. Engström-Laurent 《Rheumatology international》1997,17(2):67-73
Forty-six patients with rheumatoid arthritis (RA) and documented anemia of chronic disease (Hb <100/110 g/l) were randomized
to receive either human recombinant erythropoietin (r-HuEPO, n = 36, 300 U/kg body weight) or placebo (n = 10) for 12 weeks in a multicenter study. An adequate response was defined as elevation of Hb≥120 g/l. Relevant clinical
and laboratory assessments were made to evaluate efficacy and secure safety. A significant elevation in Hb from week 10 onwards
was noted in twenty-six patients (five drop-outs) out of nine patients receiving placebo (one drop-out) (12±1.2 g/l vs 4±0.5
g/l; Hb elevation from 95 g/l to 107 g/l vs 93 g/l to 97 g/l, P<0.05). Only 14.6%, however, were considered responders according to preset criteria. In the responders a lower initial CRP,
a significant reduction in ESR but not in CRP was seen compared to the remaining r-HuEPO group. A significant elevation of
energy level was noted in the r-HuEPO group; otherwise, no differences in clinical variables were seen. No serious adverse
effects were noted. When analyzing patients receiving oral iron in combination with r-HuEPO and adding five additional, openly
selected patients receiving both adequate iron supplementation and r-HuEPO, there was a significant weekly elevation of Hb
from week 8 onwards in favor of combination therapy over the ones only receiving r-HuEPO (18±1.1 g/l vs 7±1.1 g/l, P<0.05). The initial six responders had now reached ten of whom seven belonged to the combination therapy group. Response to
r-HuEPO in RA patients appears to be dependent on availability of iron and on the degree of inflammation. If r-HuEPO treatment
is considered, iron deficiency should always be corrected and strenous efforts should have been made to control the disease
itself.
Received: 21 February 1997 / Accepted: 21 April 1997 相似文献
94.
Hookana E Junttila MJ Särkioja T Sormunen R Niemelä M Raatikainen MJ Uusimaa P Lizotte E Peuhkurinen K Brugada R Huikuri HV 《Journal of cardiovascular electrophysiology》2008,19(7):743-747
Introduction: We screened the candidate genes from a Finnish family in which the mother was resuscitated from ventricular fibrillation and the daughter died suddenly without any prior cardiac symptoms.
Methods and Results: In addition to screening of potential structural gene mutations, phenotyping of the proband and medico-legal autopsy of the victim of the sudden death, including histopathological examinations, were performed. Genetic screening revealed an R541C mutation in the lamin A/C gene both in the proband and her daughter. None of the 16 first- or second-degree relatives, or 96 unrelated healthy subjects, carried the same mutation. In the proband, the size and the global function of the left ventricle (LV) were normal, but a local hypokinesia and thinning of inferoposterior area of the LV were seen in 2D echocardiography and magnetic resonance imaging. Coronary angiogram and the results of the electrophysiological study were normal. Autopsy of the victim of sudden death showed localized thinning and fibrosis in the inferoposterior area of the LV, with only minimal fibrosis in the right ventricle and no abnormalities in the interventricular septum.
Conclusion: These observations indicate that a fatal or near-fatal cardiac arrhythmia can be the first clinical manifestation of a "de novo" mutation R541C of the lamin A/C gene. Replacement of cardiac myocytes by fibrosis seems to be the predominant pathologic-anatomic finding. 相似文献
Methods and Results: In addition to screening of potential structural gene mutations, phenotyping of the proband and medico-legal autopsy of the victim of the sudden death, including histopathological examinations, were performed. Genetic screening revealed an R541C mutation in the lamin A/C gene both in the proband and her daughter. None of the 16 first- or second-degree relatives, or 96 unrelated healthy subjects, carried the same mutation. In the proband, the size and the global function of the left ventricle (LV) were normal, but a local hypokinesia and thinning of inferoposterior area of the LV were seen in 2D echocardiography and magnetic resonance imaging. Coronary angiogram and the results of the electrophysiological study were normal. Autopsy of the victim of sudden death showed localized thinning and fibrosis in the inferoposterior area of the LV, with only minimal fibrosis in the right ventricle and no abnormalities in the interventricular septum.
Conclusion: These observations indicate that a fatal or near-fatal cardiac arrhythmia can be the first clinical manifestation of a "de novo" mutation R541C of the lamin A/C gene. Replacement of cardiac myocytes by fibrosis seems to be the predominant pathologic-anatomic finding. 相似文献
95.
Ylihärsilä H Eriksson JG Forsén T Laakso M Uusitupa M Osmond C Barker DJ 《Journal of hypertension》2004,22(7):1283-1287
OBJECTIVE: The combination of small birth size and the Pro12Pro variant of the peroxisome proliferator-activated receptor-gamma 2 (PPAR-gamma 2) gene has been shown to be associated with insulin resistance, which is linked to hypertension. We examined whether the association between small body size at birth and adult blood pressure is modulated by PPAR-gamma 2 gene polymorphism, and whether the use of any class of antihypertensive medication is related to birth size. DESIGN AND METHODS: A total of 500 subjects from an original epidemiological cohort of 7086 men and women aged 65-75 years attended a clinical study. Two hundred and eight of them (73 men and 135 women) were taking antihypertensive medication and are included in this study. The Pro12Ala polymorphism of the PPAR-gamma 2 gene was determined using the polymerase chain reaction single-strand conformation polymorphism method. RESULTS AND CONCLUSIONS: Hypertensive subjects with low birth weight or short length at birth and the Pro12Pro variant had raised systolic blood pressure. We suggest that insulin resistance enhances the regulatory responses of the renin-angiotensin system, leading to raised blood pressure levels. Those hypertensive subjects who had small birth size and the Pro12Pro variant tended to use angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers (ACEI/ARB). This could be because insulin resistance interacts with the renin-angiotensin system in ways that make ACEI/ARB an effective therapy. Alternative explanations include more severe and treatment resistant hypertension, leading to application of ACEI/ARB, or co-morbid conditions, such as myocardial infarction and type 2 diabetes, known to be linked to low birth weight. 相似文献
96.
Sillanaukee P Kääriäinen J Sillanaukee P Poutanen P Seppä K 《Alcoholism, clinical and experimental research》2002,26(9):1359-1364
Background To study the occurrence and documentation of substance use related outpatient visits in specialized health care.
Methods The diagnosis recorded in retrospective discharge data in Tampere University Hospital for 6 years was compared with the prospective data gathered from separately completed forms added during an 8-week period to every outpatient's discharge data. In this form, the relation of substance use and the actual reason for the consultation were specifically elicited.
Results On the basis of diagnoses, retrospectively, 0.4% (6,666 of 1,555,898) of outpatient visits were caused by substance use. In the prospective part of the study, 5.6% of visits (1,401/25,014) were related to substance use. Retrospective study demonstrated 2% prevalence of substance use, whereas prospective study showed 36% substance use–related visits at the emergency room. According to the retrospective discharge data, alcohol-related organ damages were the major reason for substance use–related outpatient visits. In the prospective study, the proportion of acute traumas was most prevalent.
Conclusions Our study indicates that substance use–related visits often remain undetected in specialized health care. Substance use–related visits were underdocumented/undetected in the emergency room. Using a simple separate form could dramatically increase the detection of substance use–related visits. 相似文献
Methods The diagnosis recorded in retrospective discharge data in Tampere University Hospital for 6 years was compared with the prospective data gathered from separately completed forms added during an 8-week period to every outpatient's discharge data. In this form, the relation of substance use and the actual reason for the consultation were specifically elicited.
Results On the basis of diagnoses, retrospectively, 0.4% (6,666 of 1,555,898) of outpatient visits were caused by substance use. In the prospective part of the study, 5.6% of visits (1,401/25,014) were related to substance use. Retrospective study demonstrated 2% prevalence of substance use, whereas prospective study showed 36% substance use–related visits at the emergency room. According to the retrospective discharge data, alcohol-related organ damages were the major reason for substance use–related outpatient visits. In the prospective study, the proportion of acute traumas was most prevalent.
Conclusions Our study indicates that substance use–related visits often remain undetected in specialized health care. Substance use–related visits were underdocumented/undetected in the emergency room. Using a simple separate form could dramatically increase the detection of substance use–related visits. 相似文献
97.
BACKGROUND/AIMS: To investigate changes in the histology and the Helicobacter pylori (H. pylori) prevalence and density of the gastric mucosa, as well as in fasting serum gastrin and serum pepsinogen I, depending on completeness of vagotomy, and in cases of recurrent ulcer, during 14 years after operation in duodenal ulcer patients. METHODOLOGY: 122 vagotomized duodenal ulcer patients were studied twice on average 9 and 14 years after operation. The presence of recurrent ulcer and completeness of vagotomy were assessed simultaneously endoscopically and by endoscopic Congo red test. The histology of the gastric antrum and corpus mucosa was assessed in accordance with the Sydney system. The amount of H. pylori in the specimens was detected by microscopic counting; gastrin and pepsinogen I in serum were determined radioimmunologically. RESULTS: During the 14-year follow-up period, complete vagotomy patients were characterized by a smaller amount of active antrum gastritis and a larger amount of active chronic corpus gastritis involving corpus atrophy in 46% of cases 14 years after operation. Recurrent ulcer patients were characterized by a significantly higher prevalence of high-grade H. pylori colonization and active mucosal inflammation in the antrum as well as by a lower level of active mucosal inflammation and atrophy in the corpus and a higher serum pepsinogen I level compared with complete vagotomy cases. The data of incomplete vagotomy patients without recurrent ulcer became more similar to those recorded for recurrent ulcer patients. CONCLUSIONS: In duodenal ulcer patients, changes in the histology of the gastric antrum and corpus mucosa as well as in H. pylori prevalence and density and in serum pepsinogen I levels are different depending on completeness of vagotomy during 14 years after operation. 相似文献
98.
Rantapää-Dahlqvist S 《Scandinavian journal of rheumatology》2005,34(2):83-96
A positive rheumatoid factor (RF) test has been included as one of the criteria for the diagnosis of rheumatoid arthritis (RA) according to the 1987 classification criteria of the American College of Rheumatology (ACR). During the past 20-30 years many different autoantibodies have been described in patients with RA. The presence of some of the autoantibodies in RA directed against various autoantigens, such as anti-neutrophil cytoplasmic antibodies, anti-nuclear antibodies, antibodies against interleukin-1 (IL-1), anti-cardiolipin antibodies, and antibodies against oxidized low density lipoprotein, is not specific for RA and these are not discussed here. This review summarizes the most relevant autoantibodies, and discusses their sensitivity, specificity, and possible diagnostic and prognostic significance in early RA. The antibodies are presented with the two clinically most relevant antibody tests first, followed by others in alphabetic order. 相似文献
99.
Lauri Toivonen Matti Viitasalo Sinikka Pohjola-Sintonen Heli Siikamki Marja Raatikka 《Clinical cardiology》1994,17(7):403-404
This report deals with two patients who suffered sustained episodes of torsade de pointes ventricular tachycardia while using the novel antimalarial drug halofantrine. Both patients had congenital long QT syndrome, and their QT interval was further prolonged at the time of the event. This first electrocardiographic documentation of ventricular arrhythmias together with halofantrine's known prolonging effect on the QT interval demonstrates that the drug has the potential to induce life-threatening arrhythmias. 相似文献
100.